GlassScriptPhysician profile
Jay Natarajan
NPI 1407542939
$2,989.74
in general payments reported to CMS, 2019-2025
10 companies · $2,596 in 2025
The $2,596 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $394 · 2025: $2,596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,784 · Travel and Lodging: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,784.08 |
| Travel and Lodging | $205.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $909.08 | 2025 | Artix Mt, Flowtriever, Limflow System |
| Boston Scientific Corporation | $709.58 | 2024-2025 | Accolade Sr |
| Philips North America LLC | $600.78 | 2024-2025 | Peripheral Vascular Undivided, Igt Devices Undivided, (Bs1) Peripheral Vascular Undivided |
| Cvrx, INC. | $184.45 | 2025 | Barostim Neo System |
| Shockwave Medical, INC | $165.75 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $130.99 | 2025 | Glidesheath Slender, Azur Cx Detachable |
| Bolton Medical INC | $115.31 | 2025 | Treo Abdominal Stent-Graft System |
| Baylis Medical Technologies INC. | $104.46 | 2025 | |
| Abbvie INC. | $50.53 | 2025 | Strattice Reconstructive Tissue Matrix Bps |
| Urgo Medical North America, LLC | $18.81 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Natarajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.